Mapping of a major osteomagenic determinant of murine leukemia virus RFB-14 to non-long terminal repeat sequences

Journal of Virology

Volumn 71, Issue 1, 1997, Pages 645-649

  Østergaard, Mette ^a   Pedersen, Lene ^a   Schmidt, Jörg ^b   Luz, Arne ^b   Lovmand, Jette ^a   Erfle, Volker ^b   Pedersen, Finn Skou ^a   Strauss, P Günter ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CLONING; CONTROLLED STUDY; DNA DETERMINATION; GENE MAPPING; LEUKEMOGENESIS; LONG TERMINAL REPEAT; LYMPHOMA; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; OSTEOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS RECOMBINANT;

EID: 0031060453     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.1.645-649.1997     Document Type: Article

References (52)

1. Belli, B., A. Patel, and H. Fan. 1995. Recombinant mink cell focus-inducing virus and long terminal repeat alterations accompany the increased leukemogenicity of the Mo+PyF101 variant of Moloney murine leukemia virus after intraperitoneal inoculation. J. Virol. 69:1037-1043.
2. Brown, D. W., B. P. Blais, and H. L. Robinson. 1988. Long terminal repeat (LTR) sequences, env, and a region near the 5′ LTR influence the pathogenic potential of recombinants between Rous-associated virus types 0 and 1. J. Virol. 62:3431-3437.
3. Chatis, P. A., C. A. Holland, J. W. Hartley, W. P. Rowe, and N. Hopkins. 1983. Role for the 3′ end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses. Proc. Natl. Acad. Sci. USA 80:4408-4411.
4. Chatis, P. A., C. A. Holland, J. E. Silver, T. N. Frederickson, N. Hopkins, and J. W. Hartley. 1984. A 3′ end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus. J. Virol. 52:248-254.
5. Coffin, J. 1984. Endogenous viruses, p. 1109-1205. In R. Weiss, N. Teich, H. Varmus, and J. Coffin (ed.), RNA tumor viruses, 2nd ed., vol. 1. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
6. D'Andrea, A. D. 1992. The interaction of the erythropoietin receptor and gp55. Cancer Surv. 15:19-36.
7. DesGroseillers, L., and P. Jolicoeur. 1984. The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential. J. Virol. 52:945-952.
8. Filardo, E. J., M. F. Lee, and E. H. Humphries. 1994. Structural genes, not the LTRs, are the primary determinants of reticuloendotheliosis virus A-induced runting and bursal atrophy. Virology 202:110-128.
9. Finkel, M. P., C. A. Reilly, Jr., B. O. Biskis, and I. L. Greco. 1973. Bone tumor viruses, p. 353-366. In C. H. G. Price and F. G. M. Ross (ed.), Bone - certain aspects of neoplasia. Butterworths Scientific Publications, London, England.
10. Furth, J. 1946. Prolongation of life with prevention of leukemia by thymectomy in mice. J. Gerontol. 1:46-54.
11. Gallagher, R. E., and R. S. Gallo. 1975. Type C RNA tumor virus isolated from cultured human acute myelogenous leukemia cells. Science 187:350-353.
12. Gimbel, W., J. Schmidt, P. G. Strauss, A. Luz, R. Brack-Werner, V. Erfle, and T. Werner. 1996. Molecular and pathogenic characterization of the RFB osteoma virus: lack of oncogenen and induction of osteoma, osteopetrosis and lymphoma. Virology 224:533-538.
13. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
14. Hallberg, B., J. Schmidt, A. Luz, F. S. Pedersen, and T. Grundström. 1991. SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus. J. Virol. 65:4177-4181.
15. Hays, E. F., and D. L. Vredevoe. 1977. A discrepancy in XC and oncogenicity assays for murine leukemia virus in AKR mice. Cancer Res. 37:726-730.
16. Holland, C. A., J. W. Hartley, W. P. Rowe, and N. Hopkins. 1985. At least four viral genes contribute to the leukemogenicity of murine retrovirus MCF 247 in AKR mice. J. Virol. 53:158-165.
17. Holland, C. A., C. Y. Thomas, S. K. Chattopadhyay, C. Koehne, and P. V. O'Donnell. 1989. Influence of enhancer sequences on thymotropism and leukemogenicity of mink cell focus-forming viruses. J. Virol. 6:1284-1292.
18. Joliot, V., K. Boroughs, F. Lasserre, J. Crochet, G. Dambrine, R. E. Smith, and B. Perbal. 1993. Pathogenic potential of myeloblastosis-associated virus: implication of ENV proteins for osteopetrosis induction. Virology 195:812-819.
19. Kay, D. G., C. Gravel, F. Pothier, A. Laperrière, Y. Robitaille, and P. Jolicoeur. 1993. Neurological disease induced in transgenic mice expressing the env gene of the Cas-Br-E murine retrovirus. Proc. Natl. Acad. Sci. USA 90:4538-4542.
20. Leib-Mösch, C., J. Schmidt, M. Etzerodt, F. S. Pedersen, R. Hehlmann, and V. Erfle. 1986. Oncogenic retrovirus from spontaneous murine osteomas. II. Molecular cloning and genomic characterization. Virology 150:96-105.
21. Lenz, J., R. Crowther, S. Klimenko, and W. Haseltine. 1982. Molecular cloning of a highly leukemogenic, ecotropic retrovirus from an AKR mouse. J. Virol. 43:943-951.
22. Lenz, J., and W. A. Haseltine. 1983. Localization of the leukemogenic determinants of SL3-3, an ecotropic, XC-positive murine leukemia virus of AKR mouse origin. J. Virol. 47:317-328.
23. Lenz, J., D. Celander, R. L. Crowther, R. Patarca, D. W. Perkins, and W. A. Haseltine. 1984. Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat. Nature 308:467-470.
24. Li, J.-P., R. K. Bestwick, C. Spiro, and D. Kabat. 1987. The membrane glycoprotein of Friend spleen focus-forming virus: evidence that the cell surface component is required for pathogenesis and that it binds to a receptor. J. Virol. 61:2782-2792.
25. Lovmand, S., N. O. Kjeldgaard, P. Jørgensen, and F. S. Pedersen. 1990. Enhancer functions in U3 of Akv virus: a role for cooperatively of a tandem repeat unit and its flanking DNA sequences. J. Virol. 64:3185-3191.
26. Lowy, D. R., E. Rands, S. K. Chattopadhyay, C. F. Garon, and G. L. Hager. 1980. Molecular cloning of infectious integrated murine leukemia virus DNA from infected mouse cells. Proc. Natl. Acad. Sci. USA 77:614-618.
27. Luz, A., A. B. Murray, and J. Schmidt. 1991. Osteoma, spontaneous and virus-induced, mouse, p. 182-291. In T. C. Jones, U. Mohr, and R. D. Hunt (ed.), Cardiovascular and musculoskeletal systems. Monographs on pathology of laboratory animals. ILSI, Springer, New York.
28. Morrison, H. L., B. Soni, and J. Lenz. 1995. Long terminal repeat enhancer core sequences in proviruses adjacent to c-myc in T-cell lymphomas induced by a murine retrovirus. J. Virol. 69:446-455.
29. Mukhopadhyaya, R., J. Richardson, V. Nazarov, A. Corbin, R. Koller, M. Sitbon, and L. Wolff. 1994. Different abilities of Friend murine leukemia virus (MuLV) and Moloney MuLV to induce promonocytic leukemia are due to determinants in both Ψ-gag-PR and env regions. J. Virol. 68:5100-5107.
30. Nexø, B. A. A plaque assay for murine leukemia virus using enzyme-coupled antibodies. 1977. Virology 77:849-852.
31. Oliff, A., K. Signorelli, and L. Collins. 1984. The envelope gene and long terminal repeat sequences contribute to the pathogenic phenotype of helper-independent Friend viruses. J. Virol. 51:788-794.
32. Ott, D. E., J. Keller, K. Sill, and A. Rein. 1992. Phenotypes of murine leukemia virus-induced tumors: influence of 3′ viral coding sequences. J. Virol. 66:6107-6116.
33. Paquette, Y., Z. Hanna, P. Savard, R. Brousseau, Y. Robitaille, and P. Jolicoeur. 1989. Retrovirus-induced murine motor neuron disease: mapping the determinant of spongiform degeneration within the envelope gene. Proc. Natl. Acad. Sci. USA 86:3896-3900.
34. Pedersen, F. S., R. L. Crowther, D. Y. Tenney, A. M. Reimold, and W. A. Haseltine. 1981. Novel leukaemogenic retroviruses isolated from cell line derived from spontaneous AKR tumour. Nature 292:167-170.
35. Pedersen, F. S., M. Etzerodt, S. Lovmand, H. Y. Dai, A. J. Bækgaard, J. Sørensen, P. Jørgensen, N. O. Kjeldgaard, J. Schmidt, C. Leib-Mösch, A. Luz, and V. Erfle. 1987. Transcriptional control and oncogenicity of murine leukemia viruses, p. 17-35. In N. O. Kjeldgaard and J. Forchammer (ed.), Viral carcinogenesis. Benzon Symposium no. 24. Munksgaard. Copenhagen.
36. Pedersen, F. S., A. Luz, and J. Schmidt. Unpublished data.
37. Pedersen, L., P. G. Strauss, J. Schmidt, A. Luz, V. Erfle, P. Jørgensen, N. O. Kjeldgaard, and F. S. Pedersen. 1990. Pathogenicity of BALB/c-derived N-tropic murine leukemia viruses. Virology 179:931-935.
38. Pedersen, L., W. Behnisch, J. Schmidt, A. Luz, F. S. Pedersen, V. Erfle, and P. G. Strauss. 1992. Molecular cloning of osteoma-inducing replication-competent murine leukemia viruses from the RFB osteoma virus stock. J. Virol. 66:6186-6190.
39. Portis, J. L., S. Czub, C. F. Garon, and F. J. McAtee. 1990. Neurodegenerative disease induced by the wild mouse ecotropic retrovirus is markedly accelerated by long terminal repeat and gag-pol sequences from nondefective Friend murine leukemia virus. J. Virol. 64:1648-1656.
40. Richardson, J., A. Corbin, F. Pozo, S. Orsoni, and M. Sitbon. 1993. Sequences responsible for the distinctive hemolytic potentials of Friend and Moloney murine leukemia viruses are dispersed but confined to the φ-gag-PR region. J. Virol. 67:5478-5486.
41. Robinson, H. L., S. S. Reinsch, and P. R. Shank. 1986. Sequences near the 5′ long terminal repeat of avian leukosis viruses determine the ability to induce osteopetrosis. J. Virol. 59:45-49.
42. Robinson, H. L., R. G. Foster, B. P. Blais, S. S. Reinsch, M. Newstein, and P. R. Shank. 1992. 5′ avian leukosis virus sequences and osteopetrotic potential. Virology 190:866-871.
43. Rosen, C. A., W. A. Haseltine, J. Lenz, R. Ruprecht, and M. W. Cloyd. 1985. Tissue selectivity of murine leukemia virus infection is determined by long terminal repeat sequences. J. Virol. 55:862-866.
44. Rowe, W. P., and T. Pincus. 1972. Quantitative studies of naturally occurring murine leukemia virus infection of AKR mice. J. Exp. Med. 135:429-436.
45. Saiki, R. K., D. H. Gelfand, S. Stoffel, S. J. Scharf, R. Higuchi, G. T. Horn, K. B. Mullis, and H. A. Erlich. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491.
46. Schmidt, J., V. Erfle, F. S. Pedersen, H. Rohmer, H. Schetters, K.-H. Marquart, and A. Luz. 1984. Oncogenic retrovirus from spontaneous murine osteomas. I. Isolation and biological characterization. J. Gen. Virol. 65:2237-2248.
47. Schofield, B. H., C. P. Barrett, S. B. Doty, F. H. J. Figge, and R. A. Robinson. 1970. Formation of virus-like particles by bone cells in mice with a high incidence of spontaneous leukemia. Science 168:588-589.
48. Shank, P. R., P. J. Schatz, L. M. Jensen, P. N. Tsichlis, J. M. Coffin, and H. L. Robinson. 1985. Sequences in the gag-pol-5′ env region of avian leukosis viruses confer the ability to induce osteopetrosis. Virology 145:94-104.
49. Simon, M. C., W. S. Neckameyer, W. S. Hayward, and R. E. Smith. 1987. Genetic determinants of neoplastic diseases induced by a subgroup F avian leukosis virus. J. Virol. 61:1203-1212.
50. Sitbon, M., H. Ellerbrok, F. Pozo, J. Nishio, S. F. Hayes, L. H. Evans, and B. Chesebro. 1990. Sequences in the U5-gag-pol region influence early and late pathogenic effects of Friend and Moloney murine leukemia viruses. J. Virol. 64:2135-2140.
51. Thomas, C. Y. 1986. AKR ecotropic murine leukemia virus SL3-3 forms envelope gene recombinants in vivo. J. Virol. 59:23-30.
52. Wang, Y., S. C. Kayman, J.-P. Li, and A. Pinter. 1993. Erythropoietin receptor (EpoR)-dependent mitogenicity of spleen focus-forming virus correlates with viral pathogenicity and processing of env protein but not with formation of gp52-EpoR complexes in the endoplasmic reticulum. J. Virol. 67:1322-1327.